National Biobank of Korea: Quality control Programs of Collected-human Biospecimens

Osong Public Health and Research Perspectives

Volumn 3, Issue 3, 2012, Pages 185-189

  Lee, Jae Eun ^a   Kim, Ji Hyun ^a   Hong, Eun Jung ^a   Yoo, Hye Sook ^a   Nam, Hye Young ^a   Park, Ok ^a  

^a Korea National Institute of Health   (South Korea)

Author keywords

Biobank; Human biospecimens; Korea Biobank Project; National Biobank of Korea; Quality control

Indexed keywords

DNA; LIQUID NITROGEN;

ARTICLE; BIOSPECIMEN; CONTAMINATION; DNA DETERMINATION; HEALTH CARE FACILITY; HEALTH PROGRAM; KOREA; LYMPHOBLASTOID CELL LINE; MEDICAL RESEARCH; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; QUALITY CONTROL; QUALITY CONTROL PROCEDURES; SAMPLING; SHORT TANDEM REPEAT; STORAGE;

EID: 84866867771     PISSN: 22109099     EISSN: 22109110     Source Type: Journal    
DOI: 10.1016/j.phrp.2012.07.007     Document Type: Article

References (26)

1. Davey Smith G., Ebrahim S., Lewis S., et al. Genetic epidemiology and public health: hope, hype, and future prospects. Lancet 2005 Oct 22-28, 366(9495):1484-1498.
2. Patel A.A., Gilbertson J.R., Parwani A.V., et al. An informatics model for tissue banks-lessons learned from the cooperative prostate cancer tissue resource. BMC Cancer 2006, 6:120.
3. Elliott P., Peakman T.C. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol 2008, 37(2):234-244.
4. Rønningen K.S., Paltiel L., Meltzer H.M., et al. The biobank of the Norwegian mother and child cohort study: a resource for the next 100 years. Eur J Epidemiol 2006, 21(8):619-625.
5. Nakamura Y. The BioBank Japan Project. Clin Adv Hematol Oncol 2007, 5(9):696-697.
6. Ahn S.J., Costa J., Emanuel J.R. PicoGreen quantitation of DNA: effective evaluation of samples pre- or post-PCR. Nucleic Acids Res 1996, 24(13):2623-2625.
7. Feigelson H.S., Rodriguez C., Robertson A.S., et al. Determinants of DNA yield and quality from buccal cell samples collected with mouthwash. Cancer Epidemiol Biomarkers Prev 2001, 10(9):1005-1008.
8. Zayats T., Young T.L., Mackey D.A., et al. Quality of DNA extracted from mouthwashes. PLoS One 2009, 4(7):e6165.
9. Cobo F., Stacey G.N., Hunt C., et al. Microbiological control in stem cell banks: approaches to standardisation. Appl Microbiol Biotechnol 2005, 68(4):456-466.
10. Halls N. Effects and causes of contamination in sterile manufacturing. Microbiological contamination control in pharmaceutical clean rooms 2004, 1-22. CRC Press, Boca Raton (FL). N. Halls (Ed.).
11. Owers K.L., James E., Bannister G.C. Source of bacterial shedding in laminar flow theatres. J Hosp Infect 2004, 58(3):230-232.
12. Uphoff C.C., Drexler H.G. Detection of mycoplasma contaminations. Methods Mol Biol 2005, 290:13-23.
13. Ryan J. Understanding and managing cell culture contamination 2002, Technical Bulletin, Corning Life Sciences.
14. Kimpton C., Gill P., D'Aloja E., et al. Report on the second EDNAP collaborative STR exercise. European DNA Profiling Group. Forensic Sci Int 1995, 71(2):137-152.
15. Fan H., Chu J.Y. A brief review of short tandem repeat mutation. Genomics Proteomics Bioinformatics 2007, 5(1):7-14.
16. Ellegren H. Heterogeneous mutation processes in human microsatellite DNA sequences. Nat Genet 2000, 24(4):400-402.
17. Bielanski A., Bergeron H., Lau P.C., et al. Microbial contamination of embryos and semen during long term banking in liquid nitrogen. Cryobiology 2003, 46(2):146-152.
18. Morris G.J. The origin, ultrastructure, and microbiology of the sediment accumulating in liquid nitrogen storage vessels. Cryobiology 2005, 50(3):231-238.
19. National Biobank of Korea. Standard Operating Procedures for Human Biospecimens; 2010.
20. Comley J. Automated biobanking-the next big step for biorespositories. Drug Discovery World Summer 2007, 49-70.
21. Lee J.E., Hong E.J., Shim S.M., et al. Bacterial contamination of blood DNA samples is associated with donor's health condition. Biopreservation and Biobanking 2010, 8(3):127-131.
22. Jeon J.P., Nam H.Y., Shim S.M., et al. Sustained viral activity of epstein-Barr virus contributes to cellular immortalization of lymphoblastoid cell lines. Mol Cells 2009, 27(2):143-148.
23. Lee J.E., Nam H.Y., Shim S.M., et al. Expression phenotype changes of EBV-transformed lymphoblastoid cell lines during long-term subculture and its clinical significance. Cell Prolif 2010, 43(4):378-384.
24. Lee J.E., Hong E.J., Nam H.Y., et al. MicroRNA signatures associated with immortalization of EBV-transformed lymphoblastoid cell lines and clinical traits. Cell Prolif 2011, 44(1):59-66.
25. Jeon J.P., Shim S.M., Nam H.Y., et al. Copy number increase of 1p36.33 and mitochondrial genome amplification in Epstein-Barr virus-transformed lymphoblastoid cell lines. Cancer Genet Cytogenet 2007, 173(2):122-130.
26. Baik S.Y., Yun H.S., Lee H.J., et al. Identification of stathmin 1 expression induced by Epstein-Barr virus in human B lymphocytes. Cell Prolif 2007, 40(2):268-281.